This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Commissariat a L'energie Atomique Et Aux Energies Alternatives, Sedac Therapeutics. Active years: 2010.
Company Filing History:
1 out of 8,807 
1 out of 1 Years Active: 2010
Title: Florence Castelli: Innovator in HLA-DP4 Ligand Selection
Introduction
Florence Castelli is a notable inventor based in Montrouge, France. She has made significant contributions to the field of molecular biology, particularly in the selection of HLA-DP4 ligands. Her innovative methods have implications for various applications in medical research and therapeutic development.
Latest Patents
Florence Castelli holds a patent for a method of selecting HLA-DP4 ligands and the applications thereof. This patent describes a process that involves incubating HLA-DP4 with a test molecule and a labeled peptide, forming respective complexes. The method includes steps for separating these complexes, detecting the HLA-DP4/labeled peptide complexes, and selecting test molecules that exhibit specific binding activities. This innovative approach has the potential to enhance the understanding of immune responses and improve therapeutic strategies.
Career Highlights
Throughout her career, Florence has worked with prominent organizations, including the Commissariat à l'Énergie Atomique et aux Énergies Alternatives and Sedac Therapeutics. Her work in these institutions has allowed her to advance her research and contribute to significant scientific advancements.
Collaborations
Florence has collaborated with esteemed colleagues, including Bertrand Georges and Cécile Buhot. These partnerships have fostered a collaborative environment that enhances the quality and impact of her research.
Conclusion
Florence Castelli's contributions to the field of HLA-DP4 ligand selection exemplify her innovative spirit and dedication to advancing scientific knowledge. Her work continues to influence research and therapeutic applications in molecular biology.